Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

108.44
+2.192.06%
Post-market: 106.47-1.9700-1.82%17:30 EDT
Volume:1.71M
Turnover:184.06M
Market Cap:12.31B
PE:32.06
High:109.63
Open:106.66
Low:105.50
Close:106.25
52wk High:111.15
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:1.41
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.74
PE(LYR):42.36

Loading ...

Halozyme appoints Darren Snellgrove CFO, effective June 8

Reuters
·
Apr 30

Halozyme Appoints Darren Snellgrove as Chief Financial Officer

THOMSON REUTERS
·
Apr 30

Halozyme Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 29

Halozyme bylaws allow majority shareholders to remove directors without cause

Reuters
·
Apr 25

Top Performing Mutual Funds' Q1 Portfolio Adjustments Highlight AI and HALO Assets

Deep News
·
Apr 23

Nexalin Advances Pivotal Insomnia Trial for HALO Clarity

TIPRANKS
·
Apr 23

Nexalin Technology enters agreements to advance HALO Clarity trial

TIPRANKS
·
Apr 22

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment

GlobeNewswire
·
Apr 22

Halozyme price target raised to $96 from $94 at Morgan Stanley

TIPRANKS
·
Apr 21

Investment Focus on Tech Innovation and HALO Assets Becomes Clearer This Year

Deep News
·
Apr 20

HALO Trading: Fleeting Trend or Enduring Investment Strategy?

Deep News
·
Apr 18

Market Opportunities Remain Plentiful in Q2, Focus on Tech and HALO Assets

Deep News
·
Apr 16

HALO Asset Revaluation: Oil & Gas ETF ICBC (159017) Focuses on Full Industry Chain

Deep News
·
Apr 16

ALX Oncology names Jeff Knight chief development and operating officer

Reuters
·
Apr 13

KKR Says Uncertainty Is Creating Opportunities In Private Markets

Benzinga_recent_news
·
Apr 10

Long-Term Growth Prospects Emerge for 'HALO' Assets Amid AI Wave

Deep News
·
Apr 09

Neogen names Jennifer Evans Stacey chief legal, compliance officer, board secretary

Reuters
·
Apr 08

Hua An Fund: Banks and HALO Assets Show Resilience, Dividend Strength Stands Out

Deep News
·
Apr 08

Halozyme CEO Helen Torley disposes of common shares worth $633,384

Reuters
·
Apr 08

BRIEF-Halozyme Announces Global Collaboration And License Agreement With Vertex Pharmaceuticals For Hypercon™ Technology

Reuters
·
Apr 07